한국 조현병 환자에서 검지-약지 길이비와 발병 연령 및 대사 장애와의 연관성 = The Association of the 2nd to 4th Digit Ratio with the Age of Onset and Metabolic Factors in Korean Patients with Schizophrenia

다국어 초록 (Multilingual Abstract)

Objectives The ratio of second to fourth digit length (2D : 4D) could be a potential epigenetic marker of sexual dimorphism reflecting prenatal testosterone exposure. Testosterone is known to affect the development of the brain through an epigenetic mechanism. The purpose of this study was to investigate the effects of exposure to fetal testosterone on the metabolic syndrome based on 2D : 4D of schizophrenia patients and the relationship with the age of onset of schizophrenia. Methods A total of 214 schizophrenia patients participated in this study. The participant's physical and blood tests were performed according to the American National Cholesterol Education Program's Third Amendment of the Metabolic Syndrome Diagnostic Criteria, and the 2D : 4D was measured by the method designed by McFadden. Data were statistically analyzed by t-test, Pearson's correlation analysis and multiple regression model analysis. Results 2D : 4D was significantly higher in female than male in both hands, and there was a statistically significant negative correlation between 2D : 4D and the age of onset of schizophrenia in male. However, 2D : 4D did not show statistically significant correlation with metabolic factors. Conclusions Fetal testosterone suggests the possibility of affecting the age of onset of schizophrenia through the epigenetic mechanism, but there is no clear relationship with metabolic factors.

참고문헌 (Reference)

1 Wu XL, "The ratio of second to fourth digit length (2D:4D) and coronary artery disease in a Han Chinese population" 10 : 1584-1588, 2013

2 Manning JT, "The ratio of 2nd to 4th digit length: a proxy for transactivation activity of the androgen receptor gene?" 59 : 334-336, 2002

3 Manning JT, "The ratio of 2nd to 4th digit length: a predictor of sperm numbers and concentrations of testosterone, luteinizing hormone and oestrogen" 13 : 3000-3004, 1998

4 Lakka HM, "The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men" 288 : 2709-2716, 2002

5 Meyer JM, "The metabolic syndrome and schizophrenia" 119 : 4-14, 2009

6 Meyer JM, "The metabolic syndrome and schizophrenia" 119 : 4-14, 2009

7 Dixon L, "The association of medical comorbidity in schizophrenia with poor physical and mental health" 187 : 496-502, 1999

8 Manning JT, "The 2nd:4th digit ratio, sexual dimorphism, population differences, and reproductive success. evidence for sexually antagonistic genes?" 21 : 163-183, 2000

9 Fink B, "The 2nd-4th digit ratio (2D:4D) and neck circumference: implications for risk factors in coronary heart disease" 30 : 711-714, 2006

10 Oyeyemi BF, "Sexual dimorphism in ratio of second and fourth digits and its relationship with metabolic syndrome indices and cardiovascular risk factors" 19 : 234-239, 2014

11 Manning JT, "Sex and ethnic differences in 2nd to 4th digit ratio of children" 80 : 161-168, 2004

12 Manning JT, "Second to fourth digit ratio and male ability in sport: implications for sexual selection in humans" 22 : 61-69, 2001

13 McFadden D, "Relative lengths of fingers and toes in human males and females" 42 : 492-500, 2002

14 Phelps VR, "Relative index finger length as a sex-influenced trait in man" 4 : 72-89, 1952

15 McEvoy JP, "Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III" 80 : 19-32, 2005

16 Weiden PJ, "Obesity as a risk factor for antipsychotic noncompliance" 66 : 51-57, 2004

17 Kilbourne AM, "Nutrition and exercise behavior among patients with bipolar disorder" 9 : 443-452, 2007

18 Carney CP, "Medical comorbidity in women and men with schizophrenia: a population-based controlled study" 21 : 1133-1137, 2006

19 Spelman LM, "Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia" 24 : 481-485, 2007

20 Ryan MC, "Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia" 160 : 284-289, 2003

21 Malas MA, "Fetal development of the hand, digits and digit ratio (2D:4D)" 82 : 469-475, 2006

22 Mukherjee S, "Family history of type 2 diabetes in schizophrenic patients" 1 : 495-, 1989

23 McCarthy MM, "Epigenetic contributions to hormonally-mediated sexual differentiation of the brain" 25 : 1133-1140, 2013

24 Scheen AJ, "Drug-induced diabetes mellitus: the exemple of atypical antipsychotics" 60 : 455-460, 2005

25 Manning JT, "Digit ratio: A pointer to fertility, behavior, and health" Rutgers University Press 2002

26 Qian W, "Digit ratio (2D:4D) in a Chinese population with schizophrenia" 98 : 45-48, 2016

27 Arató M, "Digit length pattern in schizophrenia suggests disturbed prenatal hemispheric lateralization" 28 : 191-194, 2004

28 American Diabetes Association, "Consensus development conference on antipsychotic drugs and obesity and diabetes" 12 : 362-368, 2004

29 De Hert M, "Body weight and self-esteem in patients with schizophrenia evaluated with B-WISE" 88 : 222-226, 2006

30 Scheen AJ, "Abnormal glucose metabolism in patients treated with antipsychotics" 33 : 169-175, 2007